AMD · Investment summary · as of 12 August 2026
Priced for an operating path the record does not support
Business type: Cyclical · cyclical or commodity-sensitive
The operating path required by today's price is not achievable on the evidence.
At $474.32, AMD requires a 71% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 24%.
The conditions that would settle the disagreement are dated to December 2026.
The value rests on an exit multiple of 9.8x, a terminal operating margin of 22% and a 11.8% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.
The strongest argument against this view: The MI-series accelerator franchise fails to establish a durable merchant share position and the loss is PERMANENT, not cyclical.
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | State B cyclical/capex-driven; cycle position dated per the State B requirement: all-time-high TTM revenue ($41,305m) and Data Center mix (58%), TTM GAAP operating margin 15.71% in the top decile of AMD's own 19-year filed history and rising, unconditional purchase commitments at an all-time high ($30.3bn) |
| What do we forecast? | Revenue growth of 24% demonstrated; a terminal operating margin of 22%; an exit multiple of 9.8x. |
| What does Street forecast? | Not determined — no consensus figures are on file |
| Where do we differ? | On revenue growth, the difference between what the price requires and what the business has demonstrated is -47.1 percentage points. |
| What is it worth? | Twelve-month target $376.00, -21% from the struck price. Scenario-weighted expected return net of costs -10.3%. |
| Why now? | The first dated test of the thesis falls on 26 December 2026. |
| Date or window | Event | Thesis confirmed if | Thesis weakened or refuted if |
|---|---|---|---|
| 26 December 2026 | Data Center segment revenue below $7,000m in a single quarter | Data Center segment revenue at or above $7,000m in a single quarter | Data Center segment revenue below $7,000m in a single quarter |
| any two consecutive fiscal quarters through FY2027 | Data Center segment operating margin below 20.0% in two consecutive… | Data Center segment operating margin at or above 20.0% in two consecutive quarters | Data Center segment operating margin below 20.0% in two consecutive quarters |
| any two consecutive fiscal quarters through FY2027 | GAAP gross margin below 50.0% in two consecutive quarters | GAAP gross margin at or above 50.0% in two consecutive quarters | GAAP gross margin below 50.0% in two consecutive quarters |
| 26 December 2026 | Remaining performance obligations still below $2,000m | Remaining performance obligations still at or above $2,000m | Remaining performance obligations still below $2,000m |
The MI-series accelerator franchise fails to establish a durable merchant share position and the loss is PERMANENT, not cyclical. NAMED MECHANISM (primary) - share loss to NVIDIA and to customer custom silicon: OpenAI ('up to 6 GW'), Meta ('up to 6 GW') and now Anthropic ('up to 2 GW', announced with Q2 FY2026 results) are warrant-linked deployment frameworks, not purchase commitments - RPO is $222m (0.54% of TTM revenue, down from $264m in the quarter the partner list grew), and the 10-K cancellation language stands. All three counterparties (or their partners) are simultaneously developing custom accelerators. If the next NVIDIA generation or customer ASICs take the sockets, AMD does not lose a contract; it loses a design-in it never contractually had.
Estimated probability 25%, against the 13% level at which the position would be resized. It sits above that level, so this case could not be carried at full size.
Falsifiable and fundamental — not one of them is a price condition.
On approach to the $376.00 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Met | CYCLICAL test: through-cycle gross margin > 20%. |
| Valuation | Not met | Is the operating path required by today's price achievable? |
| Liquidity | Met | 20-day ADV ~$15.5bn; size is not a constraint at any book scale. Equity is the default rung and no argument for a step above it is offered because no position is taken. |
| Downside | Met | The MI-series accelerator franchise fails to establish a durable merchant share position and the loss is PERMANENT, not cyclical. |
| Momentum | Not determined | 12-1 momentum (t-252 to t-21) = +209.3% vs SPY +17.6% over the same window; 12-month total +174.6%; 52-week range $151.14-$580.91, spot at 81.7% of the high. |
| Catalyst | Met | Window from AMD's own filed cadence: Q3 10-Q filing dates 2017-2025 run 1 November 2017 to 5 November 2025; the Q3 FY2026 report (period ending 26 September 2026) is expected late October / early November 2026. |
| Consensus | Not determined | FY2026 revenue $49,725m; FY2027 $79,581m (high $116,095m, low $57,495m); FY2027 EPS $13.78, +24.2% vs 90 days prior, 8 up / 0 down in 30 days. |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The gap between what today's price requires and what the business has demonstrated is -47.1 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is the permanent-loss mechanism: the MI-series accelerator franchise fails to establish a durable merchant share position and the loss is PERMANENT, not cyclical. The next evidence that should change the portfolio decision is the test dated 26 December 2026, or a daily close below $362.59, which forces an immediate review.